244 related articles for article (PubMed ID: 19877179)
21. Differential diagnosis of cholangiocarcinoma and IgG4-related sclerosing cholangitis by fluorescence in situ hybridization using transpapillary forceps biopsy specimens.
Kato A; Naitoh I; Miyabe K; Hayashi K; Kondo H; Yoshida M; Kato H; Kuno T; Takahashi S; Joh T
J Hepatobiliary Pancreat Sci; 2018 Mar; 25(3):188-194. PubMed ID: 29532638
[TBL] [Abstract][Full Text] [Related]
22. Suspicious brush cytology is an indication for liver transplantation evaluation in primary sclerosing cholangitis.
Boyd S; Vannas M; Jokelainen K; Isoniemi H; Mäkisalo H; Färkkilä MA; Arola J
World J Gastroenterol; 2017 Sep; 23(33):6147-6154. PubMed ID: 28970730
[TBL] [Abstract][Full Text] [Related]
23. An assessment of chromosomal alterations detected by fluorescence in situ hybridization and p16 expression in sporadic and primary sclerosing cholangitis-associated cholangiocarcinomas.
DeHaan RD; Kipp BR; Smyrk TC; Abraham SC; Roberts LR; Halling KC
Hum Pathol; 2007 Mar; 38(3):491-9. PubMed ID: 17239935
[TBL] [Abstract][Full Text] [Related]
24. Surveillance of primary sclerosing cholangitis with ERC and brush cytology: risk factors for cholangiocarcinoma.
Boyd S; Mustonen H; Tenca A; Jokelainen K; Arola J; Färkkilä MA
Scand J Gastroenterol; 2017 Feb; 52(2):242-249. PubMed ID: 27806633
[TBL] [Abstract][Full Text] [Related]
25. Many patients with primary sclerosing cholangitis and increased serum levels of carbohydrate antigen 19-9 do not have cholangiocarcinoma.
Sinakos E; Saenger AK; Keach J; Kim WR; Lindor KD
Clin Gastroenterol Hepatol; 2011 May; 9(5):434-9.e1. PubMed ID: 21334457
[TBL] [Abstract][Full Text] [Related]
26. A multivariable model using advanced cytologic methods for the evaluation of indeterminate pancreatobiliary strictures.
Fritcher EG; Kipp BR; Halling KC; Oberg TN; Bryant SC; Tarrell RF; Gores GJ; Levy MJ; Clayton AC; Sebo TJ; Roberts LR
Gastroenterology; 2009 Jun; 136(7):2180-6. PubMed ID: 19232347
[TBL] [Abstract][Full Text] [Related]
27. Outcome and prognostic factors of 391 Japanese patients with primary sclerosing cholangitis.
Tanaka A; Takamori Y; Toda G; Ohnishi S; Takikawa H
Liver Int; 2008 Aug; 28(7):983-9. PubMed ID: 18397233
[TBL] [Abstract][Full Text] [Related]
28. Biliary dysplasia in primary sclerosing cholangitis harbors cytogenetic abnormalities similar to cholangiocarcinoma.
Kerr SE; Barr Fritcher EG; Campion MB; Voss JS; Kipp BR; Halling KC; Lewis JT
Hum Pathol; 2014 Sep; 45(9):1797-804. PubMed ID: 25027853
[TBL] [Abstract][Full Text] [Related]
29. Magnetic resonance cholangiopancreatography in the diagnosis of primary sclerosing cholangitis.
Weber C; Kuhlencordt R; Grotelueschen R; Wedegaertner U; Ang TL; Adam G; Soehendra N; Seitz U
Endoscopy; 2008 Sep; 40(9):739-45. PubMed ID: 18698533
[TBL] [Abstract][Full Text] [Related]
30. Pathogenesis, diagnosis and treatment of premalignant and malignant stages of cholangiocarcinoma in primary sclerosing cholangitis.
Grimsrud MM; Folseraas T
Liver Int; 2019 Dec; 39(12):2230-2237. PubMed ID: 31216595
[TBL] [Abstract][Full Text] [Related]
31. Liver transplantation for cholangiocarcinoma: selection is essential for acceptable results.
Friman S; Foss A; Isoniemi H; Olausson M; Höckerstedt K; Yamamoto S; Karlsen TH; Rizell M; Ericzon BG
Scand J Gastroenterol; 2011 Mar; 46(3):370-5. PubMed ID: 21073376
[TBL] [Abstract][Full Text] [Related]
32. Monitoring dominant strictures in primary sclerosing cholangitis with brush cytology and FDG-PET.
Sangfelt P; Sundin A; Wanders A; Rasmussen I; Karlson BM; Bergquist A; Rorsman F
J Hepatol; 2014 Dec; 61(6):1352-7. PubMed ID: 25111173
[TBL] [Abstract][Full Text] [Related]
33. Management of primary sclerosing cholangitis.
Björnsson E
Minerva Gastroenterol Dietol; 2009 Jun; 55(2):163-72. PubMed ID: 19305376
[TBL] [Abstract][Full Text] [Related]
34. Cholangiographic findings in deteriorating primary sclerosing cholangitis.
Van Laethem JL; Devière J; Bourgeois N; Love J; Gelin M; Cremer M; Adler M
Endoscopy; 1995 Mar; 27(3):223-8. PubMed ID: 7664699
[TBL] [Abstract][Full Text] [Related]
35. Biliary dysplasia in patients with primary sclerosing cholangitis: additional value of DNA ploidity.
Halme L; Arola J; Numminen K; Krogerus L; Mäkisalo H; Färkkilä M
Liver Int; 2012 May; 32(5):783-9. PubMed ID: 22098817
[TBL] [Abstract][Full Text] [Related]
36. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.
Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228
[TBL] [Abstract][Full Text] [Related]
37. Characteristics and clinical course of primary sclerosing cholangitis in France: a prospective cohort study.
Garioud A; Seksik P; Chrétien Y; Corphechot C; Poupon R; Poupon RE; Chazouillères O
Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):842-7. PubMed ID: 19779305
[TBL] [Abstract][Full Text] [Related]
38. Peroral cholangioscopy facilitates targeted tissue acquisition in patients with suspected cholangiocarcinoma.
Liu R; Cox Rn K; Siddiqui A; Feurer M; Baron T; Adler DG
Minerva Gastroenterol Dietol; 2014 Jun; 60(2):127-33. PubMed ID: 24780947
[TBL] [Abstract][Full Text] [Related]
39. Outruling cholangiocarcinoma in patients with primary sclerosing cholangitis wait-listed for liver transplantation: A report on the Irish national experience.
Duggan WP; Brosnan C; Christodoulides N; Nolan N; Kambakamba P; Gallagher TK
Surgeon; 2023 Apr; 21(2):e83-e88. PubMed ID: 35680491
[TBL] [Abstract][Full Text] [Related]
40. Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis.
Charatcharoenwitthaya P; Enders FB; Halling KC; Lindor KD
Hepatology; 2008 Oct; 48(4):1106-17. PubMed ID: 18785620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]